輸入代號或公司名稱後按 Enter
6576

逸達

+0.90 (+1.10%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
82.8078成交張數585.00本益比10.14股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025431年增 +3.0%
毛利率202568.2%最新一期
營業利益率2025-199.9%最新一期
每股盈餘2025-5.70
會計項目走勢20182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計53.6%22.9%24.7%22.5%8.5%41.6%42.7%31.8%
營業毛利(毛損)46.4%77.1%75.3%77.5%91.5%58.4%57.3%68.2%
營業毛利(毛損)淨額46.4%77.1%75.3%77.5%91.5%58.4%57.3%68.2%
推銷費用99.9%22.3%8.3%8.4%9.3%12.6%5.0%5.8%
管理費用342.4%123.1%44.0%35.4%31.9%69.5%30.2%36.3%
研究發展費用1697.4%556.9%233.3%271.9%206.0%493.0%280.0%226.1%
營業費用合計2139.6%702.2%285.6%315.8%247.2%575.1%315.2%268.2%
營業利益(損失)-2093.3%-625.2%-210.4%-238.3%-155.7%-516.6%-257.9%-199.9%
利息收入0.5%1.6%2.8%12.1%6.8%4.2%
其他收入9.3%4.3%0.0%4.5%0.4%0.4%0.8%2.1%
其他利益及損失淨額-17.9%-3.4%0.8%-1.1%7.4%-1.3%5.2%-4.1%
財務成本淨額0.7%0.4%0.3%0.1%1.5%1.6%1.3%
營業外收入及支出合計-8.6%0.2%0.9%4.7%10.4%9.7%11.1%1.0%
稅前淨利(淨損)-2101.9%-625.0%-209.5%-233.6%-145.3%-506.9%-246.8%-199.0%
所得稅費用(利益)合計16.4%22.9%12.1%18.3%11.4%24.4%11.4%5.8%
繼續營業單位本期淨利(淨損)-2118.3%-647.9%-221.6%-251.9%-156.8%-531.3%-258.2%-204.8%
本期淨利(淨損)-2118.3%-647.9%-221.6%-251.9%-156.8%-531.3%-258.2%-204.8%
國外營運機構財務報表換算之兌換差額5.9%-2.0%-1.5%-0.9%2.9%0.0%1.9%-4.2%
後續可能重分類至損益之項目:-2.0%-1.5%-0.9%2.9%0.0%1.9%-4.2%
其他綜合損益(淨額)5.9%-2.0%-1.5%-0.9%2.9%0.0%1.9%-4.2%
本期綜合損益總額-2112.4%-649.9%-223.1%-252.8%-153.9%-531.3%-256.3%-209.0%
母公司業主(淨利∕損)-2118.3%-647.9%-221.6%-251.9%-156.8%-531.3%-258.2%-204.8%
母公司業主(綜合損益)-2112.4%-649.9%-223.1%-252.8%-153.9%-531.3%-256.3%-209.0%
基本每股盈餘-25.2%-6.8%-2.2%-2.1%-1.3%-4.2%-1.9%-1.3%
繼續營業單位淨利(淨損)-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%
稀釋每股盈餘-25.2%-6.8%-2.2%-2.1%-1.3%-4.2%-1.9%-1.3%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。